JP2010540541A5 - - Google Patents

Download PDF

Info

Publication number
JP2010540541A5
JP2010540541A5 JP2010527024A JP2010527024A JP2010540541A5 JP 2010540541 A5 JP2010540541 A5 JP 2010540541A5 JP 2010527024 A JP2010527024 A JP 2010527024A JP 2010527024 A JP2010527024 A JP 2010527024A JP 2010540541 A5 JP2010540541 A5 JP 2010540541A5
Authority
JP
Japan
Prior art keywords
alkyl
nhr
formula
halogen
butyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010527024A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010540541A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/076499 external-priority patent/WO2009042444A2/en
Publication of JP2010540541A publication Critical patent/JP2010540541A/ja
Publication of JP2010540541A5 publication Critical patent/JP2010540541A5/ja
Pending legal-status Critical Current

Links

JP2010527024A 2007-09-27 2008-09-16 レチノール関連疾患を治療するための方法及び化合物 Pending JP2010540541A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97576507P 2007-09-27 2007-09-27
US98132207P 2007-10-19 2007-10-19
PCT/US2008/076499 WO2009042444A2 (en) 2007-09-27 2008-09-16 Methods and compounds for treating retinol-related diseases

Publications (2)

Publication Number Publication Date
JP2010540541A JP2010540541A (ja) 2010-12-24
JP2010540541A5 true JP2010540541A5 (enExample) 2011-11-04

Family

ID=40512081

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010527024A Pending JP2010540541A (ja) 2007-09-27 2008-09-16 レチノール関連疾患を治療するための方法及び化合物

Country Status (8)

Country Link
EP (1) EP2205234A4 (enExample)
JP (1) JP2010540541A (enExample)
KR (1) KR20100097098A (enExample)
CN (1) CN101873852A (enExample)
AU (1) AU2008305303A1 (enExample)
CA (1) CA2699773A1 (enExample)
IL (1) IL204728A0 (enExample)
WO (1) WO2009042444A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8586571B2 (en) 2007-10-18 2013-11-19 Takeda Pharmaceutical Company Limited Heterocyclic compound
NZ596205A (en) 2009-04-16 2013-01-25 Takeda Pharmaceutical Derivatives of n-acyl-n'-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
EP2642998B1 (en) * 2010-11-24 2020-09-16 The Trustees of Columbia University in the City of New York A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease
ES2664992T3 (es) * 2010-12-02 2018-04-24 Daiichi Sankyo Company, Limited Polinucleótido monocatenario modificado
US9333202B2 (en) 2012-05-01 2016-05-10 The Trustees Of Columbia University In The City Of New York Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease
US9944644B2 (en) 2013-03-14 2018-04-17 The Trustees Of Columbia University In The City Of New York Octahydropyrrolopyrroles their preparation and use
WO2014151959A1 (en) 2013-03-14 2014-09-25 The Trustees Of Columbia University In The City Of New York N-alkyl-2-phenoxyethanamines, their preparation and use
ES2700541T3 (es) 2013-03-14 2019-02-18 Univ Columbia Octahidrociclopentapirroles, su preparación y uso
US10273243B2 (en) 2013-03-14 2019-04-30 The Trustees Of Columbia University In The City Of New York 4-phenylpiperidines, their preparation and use
JP6676541B2 (ja) 2014-04-30 2020-04-08 ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク 置換された4−フェニルピペリジン、その調製及び使用
US9944596B2 (en) * 2014-10-24 2018-04-17 Takeda Pharmaceutical Company Limited Heterocyclic compound
RS61504B1 (sr) * 2014-10-24 2021-03-31 Takeda Pharmaceuticals Co Jedinjenja heteroarila za lečenje oftalmičkih bolesti
EP4142796A4 (en) * 2020-04-29 2024-06-26 Saliogen Therapeutics, Inc. COMPOSITIONS AND METHODS FOR TREATMENT OF HEREDITARY MACULAR DEGENERATION

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2526534A (en) * 1948-07-03 1950-10-17 Dow Chemical Co Di-(aryloxy)-methanes
US4255152A (en) * 1978-09-05 1981-03-10 Ciba-Geigy Corporation Process for the dyeing of hydrophobic fibres
JPS577480A (en) * 1980-06-16 1982-01-14 Sankyo Co Ltd 4-alkoxy-6-phenoxymethyl-2-pyrone derivative
WO2005070126A2 (en) * 2004-01-08 2005-08-04 The Regents Of The University Of Colorado Methods and compositions for treating human diseases and wounds with ucp and fas inhibitors
WO2005092062A2 (en) * 2004-03-19 2005-10-06 Myriad Genetics, Inc. Compounds for neurodegenerative disorders
WO2005116010A1 (en) * 2004-05-26 2005-12-08 Merck Frosst Canada Ltd. Ep4 receptor agonist, compositions and methods thereof

Similar Documents

Publication Publication Date Title
JP2010540541A5 (enExample)
JP2005053931A5 (enExample)
JP2007522220A5 (enExample)
JP2013508373A5 (enExample)
JP2009535462A5 (enExample)
JP2009531376A5 (enExample)
JP2008540554A5 (enExample)
JP2013504593A5 (enExample)
JP2010520214A5 (enExample)
JP2013514980A5 (enExample)
JP2008510828A5 (enExample)
JP2010530897A5 (enExample)
EP2397476A3 (en) Indole derivative having PGD2 receptor antagonist activity
JP2009530268A5 (enExample)
JP2015535847A5 (enExample)
JP2018531987A5 (enExample)
JP2005538089A5 (enExample)
JP2010532365A5 (enExample)
JP2010521516A5 (enExample)
JP2008546770A5 (enExample)
JP2012509265A5 (enExample)
JP2010507590A5 (enExample)
JP2013515037A5 (enExample)
JP2010534246A5 (enExample)
JP2012511558A5 (enExample)